Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 21, 2023 11:16 ET | Source: Quantitative Biosciences Institute

UCSF QBI, University College London, and Mount Sinai Identify Shared Molecular Mechanisms Across SARS-CoV-2 Variants that Allow Virus to Thrive Despite Vaccination

- Findings show viral proteins outside of Spike across Alpha, Beta, Gamma, Delta and Omicron SARS-CoV-2 variants are responsible for innate immune suppression and escape from human immune system...
October 31, 2022 03:00 ET | Source: Quantitative Biosciences Institute

L'UCSF QBI félicite Nevan Krogan, Ph.D. en tant que lauréat du prestigieux prix français de la Légion d'honneur et accueille favorablement de nouvelles relations étroites avec l'Institut Pasteur

– Deux centres universitaires de renom forment le Centre d'excellence Institut Pasteur-UCSF QBI sur les maladies émergentes avec des opérations/sites prévus à San Francisco et Paris – SAN FRANCISCO...
October 27, 2022 08:00 ET | Source: Quantitative Biosciences Institute

UCSF QBI Congratulates Nevan Krogan, Ph.D., as a Recipient of Prestigious French Legion of Honor Award and Welcomes New, Comprehensive Relationship with Institut Pasteur

– Two Academic Powerhouses form Institut Pasteur-UCSF QBI Center of Excellence in Emerging Diseases with Planned Operations/Locations in San Francisco and Paris – SAN FRANCISCO and PARIS, Oct. 27,...
May 18, 2022 17:06 ET | Source: Quantitative Biosciences Institute

UCSF QBI and QCRG Awarded Initial $67.5 Million from NIAID/NIH to Develop Novel Therapies Against Viruses with Pandemic Potential

SAN FRANCISCO, May 18, 2022 (GLOBE NEWSWIRE) -- Scientists at the UC San Francisco (UCSF) Quantitative Biosciences Institute (QBI) and the QBI Coronavirus Research Group (QCRG) have been initially...
June 07, 2021 10:15 ET | Source: Quantitative Biosciences Institute

UPDATE - UCSF QBI and University College, London Identify Mutations in “U.K.” Strain of Coronavirus SARS-CoV-2 Responsible for Enhanced Transmissibility and Infectivity

SAN FRANCISCO, Calif. and LONDON, June 07, 2021 (GLOBE NEWSWIRE) -- In a study published online in bioRxiv today, scientists at UCSF QBI and the University College, London reported new findings on...
June 07, 2021 08:35 ET | Source: Quantitative Biosciences Institute

UCSF QBI and University College, London Identify Mutations in “U.K.” Strain of Coronavirus SARS-CoV-2 Responsible for Enhanced Transmissibility and Infectivity

SAN FRANCISCO, Calif. and LONDON, June 07, 2021 (GLOBE NEWSWIRE) -- In a study published online in bioRxiv today, scientists at UCSF QBI and the University College, London reported new findings on...
January 25, 2021 14:00 ET | Source: Quantitative Biosciences Institute

UCSF QBI and Icahn School of Medicine at Mount Sinai Scientists Report New Preclinical Data Published in Science on Potential Best-in-Class COVID-19 Anti-Viral Treatment: Plitidepsin

First studies reported on antiviral drug effects against new variant mutant “U.K.” strain of SARS-CoV-2 Plitidepsin shows potent anti-viral effect in preclinical models of original SARS-CoV-2 as well...
October 15, 2020 10:00 ET | Source: Quantitative Biosciences Institute

Team of International Scientists Identify Common Vulnerabilities Across SARS-CoV-2, SARS-CoV-1 and MERS Coronaviruses

Driven by Molecular Insights, Massive Analysis of Medical Records from ~740,000 SARS-CoV-2 Patients Reveal Treatment Regimens for Current, and Potential Future, Viral Pandemics Published Today in...
June 28, 2020 06:06 ET | Source: UCSF Quantitative Biosciences Institute

Cell Publication Elucidates How SARS-CoV-2 Dramatically Rewires Important Cell Programming; Identifies Existing Therapeutics That May Fight COVID-19

For the First Time, Images Show Rapid Spread of Infection May be Explained by Extensive Filopodia, Stringy Protrusions in Virally Infected Cells Discoveries Emanate from QBI UCSF “Blueprint Map”...
April 30, 2020 09:00 ET | Source: UCSF Quantitative Biosciences Institute

Nature Publication Highlights New ‘Blueprint’ Revealing How SARS-CoV-2 Hijacks Human Cells; Points to Drugs With Potential to Fight COVID-19 and a Drug That Aids Its Infectious Growth

SAN FRANCISCO, Calif., April 30, 2020 (GLOBE NEWSWIRE) -- An international team of more than 120 scientists has detailed the impact of 75 over-the-counter prescription and development-stage drug...